|
XRCC6BP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.962300E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.172100E-02 |
| Normal-vs-Stage2 |
5.135000E-01 |
| Normal-vs-Stage3 |
3.899800E-01 |
| Normal-vs-Stage4 |
6.338400E-01 |
| Stage1-vs-Stage2 |
3.840400E-01 |
| Stage1-vs-Stage3 |
2.856400E-01 |
| Stage1-vs-Stage4 |
1.750380E-01 |
| Stage2-vs-Stage3 |
9.618800E-01 |
| Stage2-vs-Stage4 |
8.018200E-01 |
| Stage3-vs-Stage4 |
7.371600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.992500E-02 |
| Normal-vs-AfricanAmerican |
7.309400E-01 |
| Normal-vs-Asian |
1.530170E-02 |
| Caucasian-vs-AfricanAmerican |
3.480600E-01 |
| Caucasian-vs-Asian |
3.672400E-02 |
| AfricanAmerican-vs-Asian |
6.662000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.503700E-02 |
| Normal-vs-Female |
3.119800E-01 |
| Male-vs-Female |
4.327200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.913600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.687980E-01 |
| Normal-vs-Age(61-80Yrs) |
5.324100E-02 |
| Normal-vs-Age(81-100Yrs) |
2.085600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.951050E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.179390E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.782230E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.552000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.437800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.371000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.047610E-01 |
| Normal-vs-Grade 2 |
4.882800E-03 |
| Normal-vs-Grade 3 |
1.818420E-01 |
| Normal-vs-Grade 4 |
1.911220E-01 |
| Grade 1-vs-Grade 2 |
9.705200E-01 |
| Grade 1-vs-Grade 3 |
4.878600E-01 |
| Grade 1-vs-Grade 4 |
6.045900E-02 |
| Grade 2-vs-Grade 3 |
8.785700E-02 |
| Grade 2-vs-Grade 4 |
2.788100E-04 |
| Grade 3-vs-Grade 4 |
1.519610E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.429510E-04 |
| Normal-vs-ccB subtype |
3.590200E-01 |
| ccA subtype-vs-ccB subtype |
3.04900000003272E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.206800E-01 |
| Normal-vs-N1 |
9.831000E-01 |
| N0-vs-N1 |
6.363600E-01 |
|
|
